116 related articles for article (PubMed ID: 21516014)
1. Selective IgM deficiency in CD30+ cutaneous lymphoproliferative disorder.
Saini S; Dettore AJ; Bhambhani KJ; Buck S; Poulik J; Savaşan S
J Pediatr Hematol Oncol; 2011 May; 33(4):e156-9. PubMed ID: 21516014
[TBL] [Abstract][Full Text] [Related]
2. Pyogenic variant of primary cutaneous anaplastic large-cell lymphoma: a lymphoproliferative disorder with a predilection for the immunocompromized and the young.
Papalas JA; Van Mater D; Wang E
Am J Dermatopathol; 2010 Dec; 32(8):821-7. PubMed ID: 20881832
[TBL] [Abstract][Full Text] [Related]
3. Primary cutaneous CD30+ lymphoproliferative disorder--a 10-year follow-up. A case report and differential diagnosis.
Szpor J; Dyduch G; Gałazka K; Bahyrycz J; Stój A; Tomaszewska R
Pol J Pathol; 2009; 60(1):43-8. PubMed ID: 19670703
[TBL] [Abstract][Full Text] [Related]
4. Primary cutaneous anaplastic large-cell lymphoma.
Newlove T; Loyd A; Patel R; Jelinek J; Latkowski JA
Dermatol Online J; 2010 Nov; 16(11):2. PubMed ID: 21163153
[TBL] [Abstract][Full Text] [Related]
5. Sustained response of primary cutaneous CD30 positive anaplastic large cell lymphoma to bexarotene and photopheresis.
Sheehy O; Catherwood M; Pettengell R; Morris TC
Leuk Lymphoma; 2009 Aug; 50(8):1389-91. PubMed ID: 19544141
[No Abstract] [Full Text] [Related]
6. Results of a Phase II Trial of Brentuximab Vedotin for CD30+ Cutaneous T-Cell Lymphoma and Lymphomatoid Papulosis.
Duvic M; Tetzlaff MT; Gangar P; Clos AL; Sui D; Talpur R
J Clin Oncol; 2015 Nov; 33(32):3759-65. PubMed ID: 26261247
[TBL] [Abstract][Full Text] [Related]
7. Intralymphatic Spread Is a Common Finding in Cutaneous CD30+ Lymphoproliferative Disorders.
Ferrara G; Ena L; Cota C; Cerroni L
Am J Surg Pathol; 2015 Nov; 39(11):1511-7. PubMed ID: 26371781
[TBL] [Abstract][Full Text] [Related]
8. Neutrophil/eosinophil-rich type of primary cutaneous anaplastic large cell lymphoma: a clinicopathological, immunophenotypic and molecular study of nine cases.
Kong YY; Dai B; Kong JC; Lu HF; Shi DR
Histopathology; 2009 Aug; 55(2):189-96. PubMed ID: 19694826
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic use of mistletoe for CD30+ cutaneous lymphoproliferative disorder/lymphomatoid papulosis.
Seifert G; Tautz C; Seeger K; Henze G; Laengler A
J Eur Acad Dermatol Venereol; 2007 Apr; 21(4):558-60. PubMed ID: 17374000
[No Abstract] [Full Text] [Related]
10. Primary cutaneous CD30 positive anaplastic large cell lymphoma in an adolescent.
Vaid R; Cohen B
Pediatr Dermatol; 2009; 26(6):721-4. PubMed ID: 20199449
[TBL] [Abstract][Full Text] [Related]
11. Anaplastic large-cell T-cell lymphoma.
Stein JA; Soldano AC; Latkowski JA
Dermatol Online J; 2008 May; 14(5):15. PubMed ID: 18627751
[TBL] [Abstract][Full Text] [Related]
12. Treatment of primary cutaneous CD30+ anaplastic large-cell lymphoma with radiation therapy.
Yu JB; McNiff JM; Lund MW; Wilson LD
Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1542-5. PubMed ID: 18037577
[TBL] [Abstract][Full Text] [Related]
13. Primary cutaneous CD30+ anaplastic large-cell lymphoma with generalized skin involvement and involvement of one peripheral lymph node, successfully treated with low-dose oral etoposide.
Yamane N; Kato N; Nishimura M; Ito M; Yanagi T; Osawa R
Clin Exp Dermatol; 2009 Jul; 34(5):e56-9. PubMed ID: 19438576
[TBL] [Abstract][Full Text] [Related]
14. [Neutrophil-rich, anaplastic CD30+ T cell lymphoma in conjunction with lymphomatoid papulosis].
Slotosch CM; Hörster S; Hertl M; Schultz E
Hautarzt; 2010 Jun; 61(6):511-3. PubMed ID: 19536511
[TBL] [Abstract][Full Text] [Related]
15. Loss of expression of 5-hydroxymethylcytosine in CD30-positive cutaneous lymphoproliferative disorders.
De Souza A; Tinguely M; Pfaltz M; Burghart DR; Kempf W
J Cutan Pathol; 2014 Dec; 41(12):901-6. PubMed ID: 25353265
[TBL] [Abstract][Full Text] [Related]
16. Secondary ALK negative anaplastic large cell lymphoma in a patient with lymphomatoid papulosis of 40 years duration.
Marschalkó M; Eros N; Holló P; Hársing J; Bottlik G; Bátai A; Csukly Z; Masszi T; Szentirmai Z; Fodor J; Kárpáti S; Matolcsy A; Csomor J
Am J Dermatopathol; 2010 Oct; 32(7):708-12. PubMed ID: 20644462
[TBL] [Abstract][Full Text] [Related]
17. Management of multifocal primary cutaneous CD30 anaplastic large cell lymphoma.
Shehan JM; Kalaaji AN; Markovic SN; Ahmed I
J Am Acad Dermatol; 2004 Jul; 51(1):103-10. PubMed ID: 15243534
[TBL] [Abstract][Full Text] [Related]
18. MUM1 expression in cutaneous CD30+ lymphoproliferative disorders: a valuable tool for the distinction between lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma.
Kempf W; Kutzner H; Cozzio A; Sander CA; Pfaltz MC; Müller B; Pfaltz M
Br J Dermatol; 2008 Jun; 158(6):1280-7. PubMed ID: 18410414
[TBL] [Abstract][Full Text] [Related]
19. Primary cutaneous CD30+ T-cell lymphoproliferative disorder presenting as paraphimosis: a case report and review of the literature.
McNab PM; Jukic DM; Mills O; Browarsky I
Dermatol Online J; 2011 Jul; 17(7):3. PubMed ID: 21810388
[TBL] [Abstract][Full Text] [Related]
20. Primary cutaneous CD30 positive anaplastic large cell lymphoma--report of a case treated with bexarotene.
Oliveira A; Fernandes I; Alves R; Lima M; Selores M
Leuk Res; 2011 Nov; 35(11):e190-2. PubMed ID: 21764128
[No Abstract] [Full Text] [Related]
[Next] [New Search]
